Zobrazeno 1 - 10
of 35 436
pro vyhledávání: '"B-cell maturation"'
Autor:
Supimon K; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol, University, Bangkok, Thailand., Sangsuwannukul T; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States. Electronic address: Sangsuwannukul.thanich@mayo.edu., Luangwattananun P; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol, University, Bangkok, Thailand., Yenchitsomanus PT; Siriraj Center of Research Excellence for Cancer Immunotherapy (SiCORE-CIT), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Division of Molecular Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol, University, Bangkok, Thailand. Electronic address: pathai.yen@mahidol.edu.
Publikováno v:
International immunopharmacology [Int Immunopharmacol] 2024 Dec 25; Vol. 143 (Pt 2), pp. 113480. Date of Electronic Publication: 2024 Oct 29.
Autor:
Goel U; Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA., Davis J; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Department of Hematology/Medical Oncology, The Medical University of South Carolina, Charleston, South Carolina, USA., Ahmed N; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA., Shaikh H; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USA., Lochner J; University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USA., Abdallah AO; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, Kansas, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA., Hashmi H; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.; Myeloma & Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Anwer F; Cleveland Clinic Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio, USA.; United States Myeloma Innovations Research Collaborative (USMIRC), Westwood, Kansas, USA.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Dec; Vol. 113 (6), pp. 817-823. Date of Electronic Publication: 2024 Aug 27.
Autor:
Martin J; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Cheng Q; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Laurent SA; Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany., Thaler FS; Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany., Beenken AE; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Meinl E; Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.; Biomedical Center (BMC), Medical Faculty, Ludwig-Maximilians-Universität München, 82152 Martinsried, Germany., Krönke G; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Hiepe F; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany., Alexander T; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.; Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, 10117 Berlin, Germany.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Oct 09; Vol. 25 (19). Date of Electronic Publication: 2024 Oct 09.
Autor:
Shearer T; SpringWorks Therapeutics, Inc., Stamford, Connecticut., Comstock M; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington., Williams RL Jr; SpringWorks Therapeutics, Inc., Stamford, Connecticut., Johnson MC; SpringWorks Therapeutics, Inc., Stamford, Connecticut., Cendrowicz E; ICON BioAnalytical Laboratories, Assen, the Netherlands., Leonowens C; Independent Consultant, Sanford, North Carolina., Smith M; SpringWorks Therapeutics, Inc., Stamford, Connecticut., Baughman TM; SpringWorks Therapeutics, Inc., Stamford, Connecticut., Breitbach CJ; SpringWorks Therapeutics, Inc., Stamford, Connecticut., Cheng S; SpringWorks Therapeutics, Inc., Stamford, Connecticut., Green DJ; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.; Division of Transplantation and Cellular Therapy, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Dec 01; Vol. 4 (12), pp. 3114-3123.
Autor:
Munawar U; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Theuersbacher J; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Steinhardt MJ; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Zhou X; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Han S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Nerreter S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Vogt C; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Kurian S; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Keller T; Department for Functional Materials in Medicine and Dentistry, University of Würzburg, Würzburg., Regensburger AK; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Teufel E; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Mersi J; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Bittrich M; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Seifert F; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Haider MS; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Rasche L; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Hillenkamp J; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Einsele H; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Kampik D; Department of Ophthalmology, University Hospital of Würzburg, Würzburg., Kortüm KM; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg., Waldschmidt JM; Department of Internal Medicine II, University Hospital of Würzburg, Würzburg.
Publikováno v:
Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3670-3680. Date of Electronic Publication: 2024 Nov 01.
Autor:
Xing R; Department of Hematology, Dongyang Hospital Affiliated to Wenzhou Medical University, Dongyang People's Hospital, Dongyang, Zhejiang 322100, P.R. China., Wang M; Faculty of Biology, University of Freiburg, D‑79104 Freiburg, Germany., Wang L; Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150040, P.R. China., Pan M; Faculty of Law, University of Freiburg, D‑79098 Freiburg, Germany., Wang Y; Department of Rehabilitation Medicine, Chongqing University Jiangjin Hospital, Chongqing University, Chongqing 402260, P.R. China., Zhou H; Department of Gastrointestinal Surgery, Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan 421002, P.R. China.
Publikováno v:
International journal of molecular medicine [Int J Mol Med] 2025 Feb; Vol. 55 (2). Date of Electronic Publication: 2024 Dec 13.
Autor:
Qiang W; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Lu J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Jia Y; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Liu J; Gracell Biotechnologies Ltd, Shanghai, China., Liu J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., He H; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Wang X; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Fan X; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Jin L; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Ruan Q; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Zhang Q; Gracell Biotechnologies Ltd, Shanghai, China., Shen L; Gracell Biotechnologies Ltd, Shanghai, China., Weng L; Gracell Biotechnologies Ltd, Shanghai, China., Cao W; Gracell Biotechnologies Ltd, Shanghai, China., Li W; Gracell Biotechnologies Ltd, Shanghai, China., Du J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Sep 01; Vol. 10 (9), pp. 1259-1263.
Autor:
Guo P; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Wang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China., He H; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Chen D; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Liu J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Qiang W; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Lu J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China., Liang Y; Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China., Du J; Department of Hematology, Myeloma and Lymphoma Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
Publikováno v:
Clinical and experimental immunology [Clin Exp Immunol] 2024 Aug 09; Vol. 217 (3), pp. 221-232.
Autor:
Hofer KD; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Wolfensberger N; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Bachofner A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Schneidawind C; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Stühler C; Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland., Bühler MM; Department of Pathology and Molecular Pathology, University Hospital Zürich, Zürich, Switzerland., Abela IA; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich, Switzerland.; Institute of Medical Virology, University of Zürich, Zürich, Switzerland., Müller NJ; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, Zürich, Switzerland., Zenz T; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Rösler W; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland., Khanna N; Infection Biology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University and University Hospital Basel, Basel, Switzerland., Schneidawind D; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Tübingen, Germany.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 722-725. Date of Electronic Publication: 2024 May 23.
Autor:
Chen D; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Zhu Y; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Chen Z; Department of Hematology, Henan Province Hospital of Traditional Chinese Medicine, Institute of Hematology, Henan University of Traditional Chinese Medicine, Zhengzhou, China., Jiang S; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China., He H; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Qiang W; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China., Xiang F; HRAIN Biotechnology Co., Ltd., Shanghai, China., Sun X; HRAIN Biotechnology Co., Ltd., Shanghai, China., Du J; Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3747-3756.